Search

Design Therapeutics Inc

Lezárt

11.04 3.76

Áttekintés

Árfolyamváltozás megosztása

24 óra

Jelenlegi

Minimum

10.19

Maximum

10.92

Fő mutatók

By Trading Economics

Bevétel

-2.5M

-20M

Egy részvényre jutó nyereség

-0.32

Munkavállalók

55

EBITDA

-4.5M

-22M

Ajánlások

By TipRanks

Ajánlások

Erős vétel

12 hónapos előrejelzés

+153.23% upside

Osztalékok

By Acuity

Következő eredményjelentés

2026. nov. 3.

Piaci statisztika

By TradingEconomics

Piaci kapitalizáció

-59M

683M

Előző nyitás

7.28

Előző zárás

11.04

Design Therapeutics Inc Chart

A múltbeli teljesítmény nem megbízható mutatója a jövőbeli eredményeknek.

Kapcsolódó hírek

2026. okt. 19. 23:56 UTC

AxoGen Inc is trading modestly lower in after-market hours, retracing from a brief rally that peaked above Monday's close.

2026. okt. 19. 23:56 UTC

Sabre Corp shares advanced in after-market trading, recovering from earlier lows after a week-long decline, with a higher cumulative return.

2026. okt. 19. 23:56 UTC

Royal Gold Inc is trading modestly higher in after-market hours, fluctuating around the middle of its one-month range without significant excursions.

2026. okt. 19. 23:56 UTC

Axsome Therapeutics Inc shares are trading higher in after-market hours, having pulled back from an initial gain shortly after the market closed.

2026. okt. 19. 23:56 UTC

CVR Energy Inc is trading higher in after-market hours, maintaining a steady position above its 20-day moving average since Monday's close.

2026. okt. 19. 23:56 UTC

Jack Henry & Associates Inc is down in after-market trading, having pulled back from a session low earlier.

2026. okt. 19. 23:56 UTC

Cognex Corp shares advanced modestly in after-market hours, recovering from a prior decline, but remain below their 20-day moving average.

2026. okt. 19. 23:56 UTC

Hercules Capital Inc is trading lower in after-market hours, retreating to nearly the low end of its range since Monday's close.

2026. okt. 19. 23:56 UTC

TE Connectivity PLC has advanced in after-market trading, reaching its highest point of the day after initially dipping following Monday's close.

2026. okt. 19. 23:56 UTC

Cheesecake Factory Inc shares are trading modestly lower in after-market hours, retracing from an early high following a decline since Monday's close.

2026. okt. 19. 23:56 UTC

Scholar Rock Holding Corp is trading higher in after-market hours, reaching a peak return shortly after the market reopened.

2026. okt. 19. 23:56 UTC

Kroger Co shares are trading modestly higher in after-market hours, reaching their highest level since Monday's close and above the 20-day moving average.

2026. okt. 19. 23:56 UTC

News

JP Morgan maintains Overweight rating on First Solar while lowering price target to $252, reflecting ongoing confidence in the company's future.

2026. okt. 19. 23:56 UTC

Campbell's Co shares advanced modestly in after-market trading, maintaining stability and peaking before slightly retracing within the one-month trading range.

2026. okt. 19. 23:53 UTC

PDD Holdings Inc. is advancing in after-market trading, reaching its highest level since Monday's close and remaining above its 20-day moving average.

2026. okt. 19. 23:52 UTC

DraftKings Inc shares are trading modestly lower in after-market hours, remaining below Monday's close and near the lowest point of the day.

2026. okt. 19. 23:51 UTC

Tootsie Roll Industries Inc shares advanced in after-market trading on Monday, recovering from earlier lows to a higher return by the latest observation.

2026. okt. 19. 23:51 UTC

HealthStream Inc. is trading modestly lower in after-market hours, having retraced from a brief peak earlier in the session.

2026. okt. 19. 23:51 UTC

Macy's Inc shares are trading modestly higher in after-market hours, recovering from earlier lows and positioned above its 20-day moving average.

2026. okt. 19. 23:51 UTC

Tyson Foods Inc shares advanced modestly in after-market trading, remaining strong above the 20-day moving average and near the upper end of its one-month range.

2026. okt. 19. 23:51 UTC

AMETEK Inc's shares advanced modestly in after-market trading, recovering from an initial dip and positioning around the middle of its one-month trading range.

2026. okt. 19. 23:51 UTC

Social Media

Netflix Inc shares traded modestly lower during after-market hours on Monday, following the recent firing of its Chief Content Officer and film chief.

2026. okt. 19. 23:51 UTC

Community Financial System Inc shares declined during after-market hours on Monday, reversing a trend of higher daily closes observed since last week.

2026. okt. 19. 23:51 UTC

SentinelOne Inc shares advanced modestly in after-market hours, reaching a peak cumulative return since Monday's close, though still below its 20-day moving average.

2026. okt. 19. 23:51 UTC

Event
News

Bristol-Myers Squibb announces BioNTech SE will present new clinical data at the ESMO 2026 Congress, featuring 16 abstracts on various tumor types.

2026. okt. 19. 23:51 UTC

Zoetis Inc shares traded modestly lower in after-market hours, following a notable decline that has continued since Monday's close.

2026. okt. 19. 23:51 UTC

U.S. Initial Jobless Claims Expected at 200K Amid Resilient Labor Market and Cautious Optimism in Financial Markets

2026. okt. 19. 23:51 UTC

Pending Home Sales Expected to Decline 0.5% Amid Rising Mortgage Rates and Decreased Buyer Demand, Signaling Ongoing Challenges in Housing Market

2026. okt. 19. 23:51 UTC

Pending Home Sales Data Release Expected to Reflect Decline Amid Rising Mortgage Rates and Affordability Concerns

2026. okt. 19. 23:51 UTC

News

ServisFirst Bancshares reports Q3 earnings of $0.80 per share and revenue of $172.9 million, both below analyst expectations, contributing to a decline in after-market trading.

Társak összehasonlítása

Árváltozás

Design Therapeutics Inc Előrejelzés

Célár

By TipRanks

153.23% elmozdulás felfelé

12 hónapos előrejelzés

Átlag 26.108 USD  153.23%

Magas 40.54 USD

Alacsony 20 USD

5 Wall Street elemző 12 hónapos célárain alapulva a(z)Design Therapeutics Inc termékhez az elmúlt 3 hónapban.

Értékelési konszenzus

By TipRanks

Erős vétel

5 ratings

5

Vétel

0

Tartás

0

Eladás

Pénzügyek

Értékesítési és adminisztrációs költségek

Üzemeltetési költségek

Adózás előtti nyereség

Értékesítés

Értékesítési költség

Értékesítési bruttó nyereség

Kamatköltség a hitelre

EBITDA

Üzemi nyereség

$

Rólunk Design Therapeutics Inc

Design Therapeutics, Inc. a biopharmaceutical company, researches, designs, develops, and commercializes small molecule therapeutic drugs for the treatment of genetic diseases in the United States. The company utilizes its GeneTAC platform to design and develop therapeutic candidates for inherited diseases caused by nucleotide repeat expansion. Its lead product candidates for potentially disease-modifying treatment comprises Friedreich Ataxia, a monogenic, autosomal recessive, progressive multi-system disease that affects organ systems dependent on mitochondrial function that brings to neurological, cardiac, and metabolic dysfunction; Myotonic Dystrophy Type-1, a dominantly-inherited, monogenic progressive neuromuscular disease affecting skeletal muscle, heart, brain, and other organs; Fuchs Endothelial Corneal Dystrophy, a genetic eye disease characterized by bilateral degeneration of corneal endothelial cells and progressive loss of vision; and Huntington's Disease, a dominantly inherited, monogenic neurodegenerative disease characterized by movement, cognitive, and psychiatric disorders. Design Therapeutics, Inc. was incorporated in 2017 and is headquartered in Carlsbad, California.
help-icon Live chat